¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

°Ç±¹´ëÇб³º´¿ø 2019 APECS (Advances in Peripheral EndovasCular Strategies) : 2019-11-23

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
°Ç±¹´ëÇб³º´¿ø 2019 APECS (Advances in Peripheral EndovasCular Strategies) : 2019-11-23
±³À°ÀÏÀÚ : 2019-11-23
±³À°Àå¼Ò : °Ç±¹´ëÇб³º´¿ø ´ë°­´ç(B3)  
±³À°ÁÖÁ¦ : 2019 APECS (Advances in Peripheral EndovasCular Strategies)
ÁÖÃÖ±â°ü : °Ç±¹´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¿µ»óÀÇÇаú  
´ã´çÀÚ : ÇÔ»óÇù
¿¬¶ôó : 02-3144-2227  
À̸ÞÀÏ : apecsmeeting@gmail.com      
±³À°Á¾·ù : ¿µ»óÀÇÇаú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 5ºÐ  
¼¼ºÎ¼ö°­·á : 30,000¿ø      
ºñ°í »çÀüµî·Ï½Ã µî·Ïºñ ¹«·á ÇöÀåµî·Ï½Ã Àü¹®ÀÇ:3¸¸¿ø, ±âŸ:1¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-23  09:00~09:10 When to go bypass surgery or pick up the endovascular devices in aortoiliac lesions?  ÀÌ»ó¼ö(ºÎ»êÀÇ´ë ¾ç»ê) 
±³À°½Ã°£ 11-23  09:10~09:20 Stent vs Stent-graft & Balloon vs self-expandable stent or stent-graft for aortoiliac lesions: do they make different results?  Peter Drescher(West Allis Memorial Hosp.) 
±³À°½Ã°£ 11-23  09:20~09:30 Mainly aortic stenoocclusive lesions without iliac involvement. What strategies we can try?  ±èÀå¿ë(°¡Å縯ÀÇ´ë ¼­¿ï) 
±³À°½Ã°£ 11-23  09:30~10:00 Live Case 1. Stent / stent-graft  ¹Ú»ó¿ì,ȲÁøÈ£,±Ç¿ë¿ø,¹ÎÁö¿µ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-23  10:00~10:10 Uniiliac endovascular management: When do we put a stent or stent-graft in contralateral non-diseased iliac artery?  °í¿µ±¹(¿¬¼¼ÀÇ´ë ½ÅÃÌ) 
±³À°½Ã°£ 11-23  10:10~10:20 Things that matter when you have to choose between DCB and DES?  Àü¿ë¼±(ÀÎÇÏÀÇ´ë) 
±³À°½Ã°£ 11-23  10:20~10:30 The underrated bluechip: Supera stent for calcified femoropopliteal arteries  ¹Ú»ó¿ì(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-23  10:30~10:35 Do we need to avoid stent placement in common femoral artery?  ÃµÈ£Á¾(°¡Å縯ÀÇ´ë ÀºÆò) 
±³À°½Ã°£ 11-23  10:35~10:40 Hybrid operation should be gold standard in common femoral artery  ¹Ú±Ù¸í(ÀÎÇÏÀÇ´ë) 
È޽Ġ11-23  10:40~10:50 Coffee break  () 
±³À°½Ã°£ 11-23  10:50~10:55 What is the current issue on safety of drug device for femoropopliteal artery?  ±èÁ¤È£(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 11-23  10:55~11:05 What weaknesses can be exposed in metaanalysis on drug devices for femoropopliteal artery?  À̼±Èñ(°¡Ãµ´ë °£È£Çаú) 
±³À°½Ã°£ 11-23  11:05~11:15 Which opinion do we need to focus on? – Increased mortality issue with paclitaxel devices  ¹Ú»ó¿ì(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-23  11:15~11:20 Slow flow phenomenon after DCB istration: Is low dose of paclitaxel superior to high dose?  À̽Âȯ(¿ï»êÀÇ´ë ¼­¿ï¾Æ»ê) 
±³À°½Ã°£ 11-23  11:20~11:25 Lessons the Lutonix AVF study  Peter Drescher(West Allis Memorial Hosp.) 
±³À°½Ã°£ 11-23  11:25~11:30 Preliminary results of DCB for failing AVG in Korean RCT, with my best and worst cases  ±¸µ¿¾ï(¼øõÇâÀÇ´ë ¼­¿ï) 
±³À°½Ã°£ 11-23  11:30~12:00 Live Case 2. Drug devices  ¹Ú»ó¿ì,ȲÁøÈ£,±Ç¿ë¿ø,¹ÎÁö¿µ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-23  12:00~12:10 Can ¡°FlexArm¡± give us ¡°flexible positioning¡±?  Peter Belei(Philips, Singapore) 
±³À°½Ã°£ 11-23  12:10~12:20 CO2 angiography : how to improve image quality and reduce discomforts  ±è¿µÈ¯(´ë±¸°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-23  12:20~12:30 IVUS for lower limb arteries: what benefits do we have over US, CT or DSA?  Uei Pua(Tan Tock Seng Hospital, Singapore) 
±³À°½Ã°£ 11-23  12:30~12:40 MR angiography: where are we today, and what do we expect tomorrow?  ÀÌÈ°(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-23  12:45~13:20 Special Lecture: ¡°Can DCB work in BTK?¡±  Peter Drescher(West Allis Memorial Hosp.) 
±³À°½Ã°£ 11-23  13:20~13:30 When do you go rotational or directional atherectomy? Do lesion characteristics matter?  Á¶ÁøÇö(°æÈñÀÇ´ë) 
±³À°½Ã°£ 11-23  13:30~13:40 When you try retrograde access or pick up re-entry catheter?  ¹èÀçÀÍ(¹ÎÆ®º´¿ø) 
±³À°½Ã°£ 11-23  13:40~13:45 Piercing technique: is it too aggressive or necessary to do?  ³ª½Â¿î(°í·ÁÀÇ´ë ±¸·Î) 
±³À°½Ã°£ 11-23  13:45~13:55 Deep venous arterialization: Can we make clinical success even without dedicated devices?  ¿øÁ¦È¯(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 11-23  13:55~14:05 How to decide when we complete endovascular management for BTK or BTA?  ±è¼öÈ«(ºÎ»êº¸Èƺ´¿ø) 
±³À°½Ã°£ 11-23  14:05~14:35 Live Case 3. Atherectomy or drug device  ¹Ú»ó¿ì,ȲÁøÈ£,±Ç¿ë¿ø,¹ÎÁö¿µ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-23  14:35~14:45 Choice between 0.014 vs. 0.018 guide wires and balloons: what are the indications?  °íÀ±¼®(°¡Å縯ÀÇ´ë ¼­¿ï) 
±³À°½Ã°£ 11-23  14:45~14:55 Does surgery have any role for BTA lesions?  º¯½ÂÀç(¿ø±¤ÀÇ´ë) 
±³À°½Ã°£ 11-23  14:55~15:05 Let¡¯s change the lytic drug: Urokinase is running out  ¹Ú»óÈ£(¼øõÇâÀÇ´ë õ¾È) 
±³À°½Ã°£ 11-23  15:05~15:15 Does Angiojet work for multilevel occlusion?  ±èÁø¿ì(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 11-23  15:15~15:25 Rotarex has many big competitors. When do we need to pick it up?  ±èÇü¿í(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 11-23  15:25~15:35 How to obtain technical success of closure device in punctured area with heavy calcium: choice of devices and any tips?  ¾Èö¹Î(¿¬¼¼ÀÇ´ë ½ÅÃÌ) 
È޽Ġ11-23  15:35~15:45 Coffee break  () 
±³À°½Ã°£ 11-23  15:45~15:50 New DCB trial with ¡°Made-in-Korea¡±  À̺´Âù(Àü³²ÀÇ´ë È­¼ø) 
±³À°½Ã°£ 11-23  15:50~16:00 Is radial artery too far away for visceral/peripheral interventions?  Á¶¼ö¹ü(ÀÌ´ëÀÇ´ë) 
±³À°½Ã°£ 11-23  16:00~16:30 Live Case 4. BTK  ¹Ú»ó¿ì,ȲÁøÈ£,±Ç¿ë¿ø,¹ÎÁö¿µ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-23  16:30~16:40 We have many IVC filters: Are there different tips for retrieval or different indications?  Á¶Á¤Çö(µ¿¾ÆÀÇ´ë) 
±³À°½Ã°£ 11-23  16:40~16:45 Why such growing number of lawsuits regarding temporary IVC filters in the US?  Peter Drescher(West Allis Memorial Hosp.) 
±³À°½Ã°£ 11-23  16:45~16:55 Do we need to avoid covering contralateral iliac vein while putting venous stent? What is the role of IVUS and how to handle IVUS?  Uei Pua(Tan Tock Seng Hospital, Singapore) 
±³À°½Ã°£ 11-23  16:55~17:00 Cover or block the leak: is that all for aortoiliac trauma?  ±èâ¿ø(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 11-23  17:00~17:10 Antiplatelet and anticoagulation therapy for peripheral vascular disease  Peter Drescher(West Allis Memorial Hosp.) 
±³À°½Ã°£ 11-23  17:10~17:20 Robot for endovascular treatment: How close to us  ¿øÁ¾À±(¿¬¼¼ÀÇ´ë ½ÅÃÌ) 
±³À°½Ã°£ 11-23  17:20~17:30 Transarterial embolization for limb artreries: is it great pain killer?  È²ÁøÈ£(°Ç±¹ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" °Ç±¹´ëÇб³º´¿ø 2019 APECS (Advances in Peripheral EndovasCular Strategies) : 2019-11-23""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Ä¥°î°æºÏ´ëÇб³º´¿ø È£½ºÇǽº¿ÏÈ­ÀÇ·áÁ¾»çÀÚ º¸¼ö±³À° : 2019-11-23
´ÙÀ½±Û ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø ¿Ü°ú ½ÉÆ÷Áö¿ò 2019 : 2019-11-23
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20998 °æ±â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ °æÀÎÁöȸ Á¦7ȸ °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-23 0 4 2024-06-16
20997 ¼­¿ï Á¦18ȸ ´ëÇѺñ°úÇÐȸ ½ÉÆ÷Áö¾ö : 2024-06-23 0 3 2024-06-16
20996 ÀÎõ ÀÎÇÏ´ëÇб³º´¿ø Á¦6ȸ ÀÎÇÏÇǺνÉÆ÷Áö¾ö : 2024-06-22 0 2 2024-06-16
20995 ¼­¿ï Á¦23ȸ Çѱ¹Á¤¸Æ°æÀ念¾çÇÐȸ Çмú´ëȸ ¹× 2024 ±¹Á¦Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-22 0 2 2024-06-16
20994 ¼­¿ï 2024³â Á¦2Â÷ ´ëÇѳëÀÎÀÇÇÐ ¼¼ºÎÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-06-22 0 4 2024-06-16
20993 ¼­¿ï ´ëÇѼҾÆÀçÈ°¹ß´ÞÀÇÇÐȸ Çмú´ëȸ : 2024-06-22 0 0 2024-06-16
20992 °æ±â 2024³â ¾È¾ç½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-22 0 0 2024-06-16
20991 ¼­¿ï ´ëÇѼҾƳ»ºÐºñÇÐȸ Á¦18Â÷ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-06-22 0 0 2024-06-16
20990 ¼­¿ï 2024³â Çѱ¹ºÐ¼®½É¸®ÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-22 0 0 2024-06-16
20989 ¼­¿ï 2024 ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ ³ú½Å°æÁ¶Àý Moving Symposium : 2024-06-22 0 0 2024-06-16
20988 ¼­¿ï 2024 Á¦ 13ȸ ´ëÇѺñ´¢»ý½Ä±âÅëÇÕ±â´ÉÀÇÇבּ¸È¸ Çмú´ëȸ : 2024-06-22 0 15 2024-06-14
20987 Ãæ³² 2024³â ´ëÇÑ°í°üÀýÇÐȸ Áø·áÁöħ ½ÉÆ÷Áö¿ò : 2024-06-22 0 17 2024-06-14
20986 ±¤ÁÖ Á¦24ȸ ´ëÇÑôÃ߽Űæ¿Ü°úÇÐȸ È£³²Áöȸ Á¤±âÇмú´ëȸ : 2024-06-22 0 17 2024-06-14
20985 °æ±â ´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO Annual Academy for young oncologists(2ÀÏÂ÷) : 2024-06-22 0 12 2024-06-14
20984 °æºÏ ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦43Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-22 0 11 2024-06-14
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷